Azenta Life Sciences Reports Results of First Quarter of Fiscal 2022, Ended December 31, 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Azenta, Inc. (AZTA) PT Lowered to $115 at Needham & Company
February 9, 2022 6:59 AM ESTNeedham & Company analyst David Saxon lowered the price target on Azenta, Inc. (NASDAQ: AZTA) to $115.00 (from $155.00) while maintaining a Buy rating.
The analyst commented, "AZTAs F1Q22 revenue and EPS beat consensus and management provided F2Q22 revenue and EPS guidance that... More
Azenta, Inc. (AZTA) Tops Q1 EPS by 4c
February 8, 2022 4:07 PM ESTAzenta, Inc. (NASDAQ: AZTA) reported Q1 EPS of $0.12, $0.04 better than the analyst estimate of $0.08. Revenue for the quarter came in at $140 million versus the consensus estimate of $135.42 million.
GUIDANCE:
Azenta, Inc. sees Q2 2022 EPS of $0.07-$0.15, versus the consensus of... More
